News in 2021

CMM Spotlight Series: Dr Jon Tyrrell 30 November 2021 Jon Tyrrell is a lecturer in microbiology within CMM. Alongside his teaching, his research focuses on antibiotic resistance and its evolution. He is also the school’s digital champion and co-lead on CMM’s transition to online and blended learning. Public engagement and public-involved research is also a keen interest of his. Continuing our Spotlight Series, PGR students Luis Martinez Robles and Will Gibbs interviewed Dr Tyrrell to find out more about his research, inclusive teaching and developing a work/life balance as a parent.
CMM Spotlight Series: Dr Isabel Murillo Cabeza 28 October 2021 As part of our CMM Spotlight Series, PhD students' Carissa Wong and Michaela Gregorova interview CMM Lecturer in Microbiology Dr Isabel Murillo Cabeza to discuss her own journey into science, along with her thoughts on how we can change the scientific culture for women right now.
Celebrating Postdoc Appreciation Week 2021 22 September 2021 It is Postdoc Appreciation Week from 20-24 September 2021 and the School of Cellular and Molecular Medicine would like to celebrate and recognise the hard work and achievements of our postdoctoral community.
CMM Spotlight Series: Professor Anne Ridley 10 August 2021 Continuing our CMM Spotlight Series, PhD students' Carissa Wong and Michaela Gregorova turn the lens on Women in STEM, interviewing Professor Anne Ridley FRS FRSB FMedSci FRMS - Professor of Cell Biology and Head of School here at CMM. Her research has made seminal contributions to our understanding of cancer progression and inflammation through her work on cell migration. Her work initiated a whole research field studying the function and regulation of Rho GTPases, and has influenced many areas of medical research, from cancer metastasis to cardiovascular and infectious diseases.
Congratulations to our 2021 graduating students! 28 July 2021 We were delighted to throw a 'Virtual Celebration' for our graduating students of 2021 in lieu of an in-person event this year.
CMM Spotlight Series: Dr Bethan Lloyd-Lewis 28 June 2021 As part of our CMM Spotlight Series, PhD students' Drinalda Cela and Michaela Gregorova interview Dr Bethan Lloyd-Lewis - a Vice Chancellor's Fellow in CMM. Her research is focused on examining the biological mechanisms that regulate epithelial cell fate during tissue development and the early stages of cancer, with a particular interest in breast biology. The aim of her research is ultimately to define improved approaches for breast cancer prevention and early detection, in addition to informing the development of new chemo-preventative and therapeutic strategies.
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy 24 June 2021 An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.
GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic 17 June 2021 The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
Young infants produce strong immune response to SARS-CoV-2, study finds 11 June 2021 Young infants show strong immune responses to SARS-CoV-2, new research has found. In particular, compared with adults, young infants produce relatively high levels of antibodies and immune cells that can specifically protect against COVID-19.
Researchers in CMM and the university continue the fight to eradicate deadly disease on World Tuberculosis Day 25 March 2021 Researchers at the University of Bristol are working on a number of different developments to finally end the TB epidemic.
CMM has been at the forefront of COVID-19 research 24 March 2021 As the COVID-19 pandemic hit the world, academics from across the School of Cellular and Molecular Medicine and the University of Bristol joined together to understand the virus and the impact of the pandemic. Today [23 March] is a year since the first UK lockdown and their research is continuing to play a key role in global efforts to overcome the disease.
Using sound to shape the future of printing 16 March 2021 Researchers have developed a way to coax microscopic particles and droplets into precise patterns by harnessing the power of sound in air. The implications for printing, especially in the fields of medicine and electronics, are far-reaching.
High fructose diets could cause immune system damage 22 February 2021 New research led by Swansea University in collaboration with researchers at the University of Bristol and the Francis Crick Institute in London has indicated that consuming a diet high in the sugar fructose might prevent the proper functioning of peoples' immune systems in ways that has, until now, largely been unknown.
Eugenia Piddini: Celebrating International Day of Women and Girls in Science 10 February 2021 Drinalda Cela, a PhD student in CMM, interviewed Professor Eugenia Piddini in celebration of the UN International Day of Women and Girls in Science, exploring her research, the critical role of women in STEM and her own experience as a first-generation academic.
CMM Research Away Day 2021 25 January 2021 The School of Cellular and Molecular Medicine came together on 12 January 2021 for their annual Research Away Day
National consortium to study the threats of new SARS-CoV-2 variants 18 January 2021 A new national research project to study the effects of emerging mutations in SARS-CoV-2 is launched on 15 January. The £2.5 million UK Research and Innovation (UKRI)-funded 'G2P-UK' National Virology Consortium will study how mutations in the virus affect key outcomes such as how transmissible it is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments.